{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:03:05Z","timestamp":1781848985900,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.061","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T07:43:07Z","timestamp":1662018187000},"page":"5806-5813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings"],"prefix":"10.1016","volume":"40","author":[{"given":"Juan F.","family":"Vesga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"M\u00e9tras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine H.A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edris","family":"Ayazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Apolloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Msimang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"John Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.061_b0005","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid2508.181491","article-title":"Crimean-Congo Hemorrhagic Fever, Herat Province, Afghanistan, 2017","volume":"25","author":"Niazi","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijid.2008.07.021","article-title":"The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002\u20132007","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Int J Infect Diseases"},{"key":"10.1016\/j.vaccine.2022.08.061_b0015","first-page":"640","article-title":"Subclinical infections with Crimean-Congo hemorrhagic fever virus","volume":"18","author":"Bodur","year":"2012","journal-title":"Turkey Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0020","first-page":"7","article-title":"Vaccine against congo-crimean haemorrhagic fever virus-bulgarian input in fighting the disease","author":"Christova","year":"2010","journal-title":"Probl Infect Parasit Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0025","doi-asserted-by":"crossref","unstructured":"Canakoglu N, Berber E, Tonbak S, Ertek M, Sozdutmaz I, Aktas M, et al. Immunization of knock-out \u03b1\/\u03b2 interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine. PLoS Negl Trop Dis 2015;9. 10.1371\/JOURNAL.PNTD.0003579.","DOI":"10.1371\/journal.pntd.0003579"},{"key":"10.1016\/j.vaccine.2022.08.061_b0030","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.061_b0035","doi-asserted-by":"crossref","unstructured":"Farzani TA, F\u00f6ldes K, Erg\u00fcnay K, Gurdal H, Bastug A, Ozkul A. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines (Basel) 2019;7. 10.3390\/VACCINES7030115.","DOI":"10.3390\/vaccines7030115"},{"key":"10.1016\/j.vaccine.2022.08.061_b0040","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/CVI.05352-11","article-title":"Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus","volume":"18","author":"Ghiasi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.08.061_b0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1017\/S0950268809991026","article-title":"The trend towards habitat fragmentation is the key factor driving the spread of Crimean-Congo haemorrhagic fever","volume":"138","author":"Estrada-Pe\u00f1a","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2022.08.061_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4081\/gh.2007.261","article-title":"An early warning system for Crimean-Congo haemorrhagic fever seasonality in Turkey based on remote sensing technology","volume":"2","author":"Estrada-Pe\u00f1a","year":"2007","journal-title":"Geospat Health"},{"key":"10.1016\/j.vaccine.2022.08.061_b0055","doi-asserted-by":"crossref","unstructured":"Vescio FM, Busani L, Mughini-Gras L, Khoury C, Avellis L, Taseva E, et al. Environmental correlates of Crimean-Congo haemorrhagic fever incidence in Bulgaria. BMC Public Health 2012;12. 10.1186\/1471-2458-12-1116.","DOI":"10.1186\/1471-2458-12-1116"},{"key":"10.1016\/j.vaccine.2022.08.061_b0060","unstructured":"World Health Organization. An R&D blueprint for action to prevent epidemics. Geneva 2016. https:\/\/www.who.int\/blueprint\/about\/r_d_blueprint_plan_of_action.pdf (accessed November 23, 2021)."},{"key":"10.1016\/j.vaccine.2022.08.061_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010454","article-title":"Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: a modelling study","volume":"16","author":"Vesga","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2019.08.016","article-title":"Descriptive epidemiology of Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: Reported cases to National Surveillance System, 2016\u20132018","volume":"88","author":"Sahak","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0075","doi-asserted-by":"crossref","unstructured":"Mofleh J, Ahmad Z. Crimean-Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008. Eastern Mediterranean Health Journal = La Revue de Sante de La Mediterranee Orientale = Al-Majallah al-Sihhiyah Li-Sharq al-Mutawassit 2012;18:522\u20136. 10.26719\/2012.18.5.522.","DOI":"10.26719\/2012.18.5.522"},{"key":"10.1016\/j.vaccine.2022.08.061_b0080","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3201\/eid1710.110061","article-title":"Crimean-Congo Hemorrhagic Fever, Afghanistan, 2009","volume":"17","author":"Mustafa","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0085","unstructured":"National institute for communicable diseases. Crimean-Congo haemorrhagic fever. Communique (Wash DC) 2022;19:3."},{"key":"10.1016\/j.vaccine.2022.08.061_b0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4269\/ajtmh.1992.47.337","article-title":"Risk of human infections with crimean-congo hemorrhagic fever virus in a South African rural community","volume":"47","author":"Fisher-Hoch","year":"1992","journal-title":"Am J Trop Med Hygiene"},{"key":"10.1016\/j.vaccine.2022.08.061_b0095","doi-asserted-by":"crossref","unstructured":"Msimang V, Weyer J, Roux C le, Kemp A, Burt FJ, Tempia S, et al. Risk factors associated with exposure to Crimean-Congo haemorrhagic fever virus in animal workers and cattle, and molecular detection in ticks, South Africa. PLoS Negl Trop Dis 2021;15. 10.1371\/JOURNAL.PNTD.0009384.","DOI":"10.1371\/journal.pntd.0009384"},{"key":"10.1016\/j.vaccine.2022.08.061_b0100","first-page":"1","article-title":"Seroprevalence of crimean-congo hemorrhagic fever in humans in the world health organization European region: a systematic review","volume":"14","author":"Monsalve-Arteaga","year":"2020","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2015.12.003","article-title":"Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges","volume":"126","author":"Leblebicioglu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2022.08.061_b0110","unstructured":"Turkey records 13 Crimean-Congo Hemorrhagic Fever deaths year to date - Outbreak News Today n.d. http:\/\/outbreaknewstoday.com\/turkey-records-13-crimean-congo-hemorrhagic-fever-deaths-year-to-date-37034\/ (accessed November 4, 2021)."},{"key":"10.1016\/j.vaccine.2022.08.061_b0115","doi-asserted-by":"crossref","unstructured":"Vesga JF, Clark MHA, Ayazi E, Apolloni A, Leslie T, Edmunds WJ, et al. Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: a modelling study. MedRxiv 2022:2022.01.20.22269558. 10.1371\/journal.pntd.0010454.","DOI":"10.1101\/2022.01.20.22269558"},{"key":"10.1016\/j.vaccine.2022.08.061_b0120","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2019.06.019","article-title":"An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool","volume":"37","author":"Bellan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.061_b0125","doi-asserted-by":"crossref","unstructured":"O\u2019neill RT. On sample sizes to estimate the protective efficacy of a vaccine. Stat Med 1988;7:1279\u201388. 10.1002\/SIM.4780071208.","DOI":"10.1002\/sim.4780071208"},{"key":"10.1016\/j.vaccine.2022.08.061_b0130","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates. Lawrence Earlbaum Associates 1988:286."},{"key":"10.1016\/j.vaccine.2022.08.061_b0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijid.2016.06.019","article-title":"Subclinical Plasmodium falciparum infections act as year-round reservoir for malaria in the hypoendemic Chittagong Hill districts of Bangladesh","volume":"49","author":"Shannon","year":"2016","journal-title":"Int J Infect Diseases"},{"key":"10.1016\/j.vaccine.2022.08.061_b0140","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4269\/ajtmh.20-1413","article-title":"Epidemiology of crimean-congo hemorrhagic fever (CCHF) in Africa-underestimated for decades","volume":"104","author":"Temur","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2022.08.061_b0145","article-title":"a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola","volume":"351","author":"The ring vaccination trial","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2022.08.061_b0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.08.061_b0155","article-title":"Sporadic outbreaks of crimean-congo haemorrhagic fever in Uganda, July 2018-January 2019","volume":"15","author":"Mirembe","year":"2021","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2022.08.061_b0160","doi-asserted-by":"crossref","unstructured":"Kizito S, Okello PE, Kwesiga B, Nyakarahuka L, Balinandi S, Mulei S, et al. <em>Notes from the Field<\/em>: Crimean-Congo Hemorrhagic Fever Outbreak \u2014 Central Uganda, August\u2013September 2017. MMWR Morbidity and Mortality Weekly Report 2019;67:646\u20137. 10.15585\/MMWR.MM6722A6.","DOI":"10.15585\/mmwr.mm6722a6"},{"key":"10.1016\/j.vaccine.2022.08.061_b0165","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3201\/eid1008.030928","article-title":"Crimean-Congo Hemorrhagic Fever in Turkey - Volume 10, Number 8\u2014August 2004 - Emerging Infectious Diseases journal - CDC","volume":"10","author":"Karti","year":"2004","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:33Z","timestamp":1759403733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22010519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22010519"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.061","relation":{"is-supplemented-by":[{"id-type":"uri","id":"http:\/\/cchfv-vaccine-trial-multicountry+(Reference+data)","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.09.22276201","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}